Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether dexmedetomidine added to morphine is effective in the treatment of chronic cancer pain.
We conduct the study in Cukurova University Faculty of Medicine Research Hospital after obtaining ethics committee approval and patient's informed consent. Patients with cancer pain are allocated into two group to receive Patient Controlled Analgesia with morphine or morphine plus dexmedetomidine.
Age
20 - 80 years
Sex
ALL
Healthy Volunteers
No
Cukurova University Faculty of Medicine Research Hospital
Adana, Turkey (Türkiye)
Start Date
November 1, 2014
Primary Completion Date
February 1, 2015
Completion Date
February 1, 2015
Last Updated
June 19, 2018
40
ACTUAL participants
Morphine
DRUG
Morphine plus dexmedetomidine
DRUG
Lead Sponsor
Cukurova University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06219408